Thursday, December 09, 2004

From CBC News:
ID Biomedical elects to sell surplus vaccine to Canada, not the U.S.
ID Biomedical, Canada's main supplier of flu vaccine, has elected to sell its remaining surplus doses of vaccine in Canada, not the United States, the company announced Tuesday.

The company had been in negotiations since early October with U.S. public health officials keen to buy the 1.2 million doses to help that country with its acute flu vaccine shortage this year. The Vancouver-based company said in a statement that it was selling the doses to the Canadian market on the request of the federal government.

No comments: